Language selection

Search

2014-10-17 - Male - 17 Years old

629299

Adverse reaction report number 629299
Latest AER version number 0
Market authorization holder AER number N/A
Initial received date 2014-10-17
Latest received date 2014-10-17
Age 17 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Pharmacist
Source of report Community
Report outcome Unknown
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization
Other medically important Yes

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XR 25MGCAPSULE, EXTENDED RELEASESuspectOral75 MilligramOnce5 Hour(s)Disturbance in attention

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Abdominal pain
Chest pain
Drug abuse
Headache
Insomnia
Palpitations
Date modified: